Literature DB >> 16915582

The effects of concurrent cannabis use among ecstasy users: neuroprotective or neurotoxic?

John E Fisk1, Catharine Montgomery, Michelle Wareing, Philip N Murphy.   

Abstract

The research evidence regarding the potential effects of ecstasy suggests that it may be neurotoxic and that its use is associated with cognitive impairment. In recent years evidence has emerged suggesting that cannabinoids, the active ingredients in cannabis, can be neuroprotective under certain conditions. Given that many ecstasy users also consume cannabis at the same time, the possibility emerges that these individuals might be less susceptible to ecstasy-related impairment. The present paper reanalyses the data from a number of previous studies, contrasting the performance of those individuals who generally consume cannabis and ecstasy at the same time with those who generally consume ecstasy on its own. The two ecstasy-using groups are compared with non-ecstasy users on a range of measures including processing speed, random letter generation, verbal and visuo-spatial working memory span, reasoning and associative learning. The two ecstasy user groups did not differ significantly from each other on any of the measures. Both user groups were significantly worse than non-ecstasy users on measures of associative learning, verbal and visuo-spatial working memory and reasoning. The results suggest that consuming cannabis at the same time as ecstasy does not reduce the likelihood of cognitive impairment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16915582     DOI: 10.1002/hup.777

Source DB:  PubMed          Journal:  Hum Psychopharmacol        ISSN: 0885-6222            Impact factor:   1.672


  3 in total

1.  The cannabinoid receptor agonist THC attenuates weight loss in a rodent model of activity-based anorexia.

Authors:  Aaron N A Verty; Megan J Evetts; Geraldine J Crouch; Iain S McGregor; Aneta Stefanidis; Brian J Oldfield
Journal:  Neuropsychopharmacology       Date:  2011-03-16       Impact factor: 7.853

2.  Effect of the CB1 cannabinoid agonist WIN 55212-2 on the acquisition and reinstatement of MDMA-induced conditioned place preference in mice.

Authors:  Carmen Manzanedo; Marta Rodríguez-Arias; Manuel Daza-Losada; Concepción Maldonado; María A Aguilar; José Miñarro
Journal:  Behav Brain Funct       Date:  2010-03-22       Impact factor: 3.759

Review 3.  Acute and non-acute effects of cannabis on brain functioning and neuropsychological performance.

Authors:  Raul Gonzalez
Journal:  Neuropsychol Rev       Date:  2007-09       Impact factor: 7.444

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.